Alicia Beatriz Penissi

Prof. Dr. Alicia Beatriz Penissi


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in BIOCELL
Verified
Journal Article
Open access
APAlicia Beatriz Penissi
Alicia Beatriz Penissi
MAMar韆I.Rudolph
Mar韆I.Rudolph
RARam髇S.Piezzi
Ram髇S.Piezzi
The purpose of this review, based on studies from our laboratory as well as from others, is to summarize salient features of mast cell immunobiology and to describe their associations with gastrointestinal mucosal defense. Gastrointestinal mast cells are involved in many pathologic effects, such as food hypersensitivity. On the other hand, they also play a protective role in defense against parasitic and microbial infections. Thus, they have both positive and negative effects, but presently the mechanisms that control the balance of these various effects are poorly known. It has been suggested that stabilization of mast cells may be a key mechanism to protect the gastrointestinal tract from injury. Few molecules are known to possess both mast cell stabilizing and gastrointestinal cytoprotective activity. These include zinc compounds, sodium cromoglycate, FPL 52694, ketotifen, aloe vera, certain flavonoids such as quercetin, some sulfated proteoglycans such as chondroitin sulfate and dehydroleucodine. Dehydroleucodine, a sesquiterpene lactone isolated from Artemisia douglasiana Besser, exhibits anti-inflammatory and gastrointestinal cytoprotective action. The lactone stimulates mucus production, and inhibits histamine and serotonin release from intestinal mast cells. The lactone could act as a selective mast cell stabilizer by releasing cytoprotective factors and inhibiting pro-inflammatory mast cell mediators.

1 June 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
APAlicia Beatriz Penissi
Alicia Beatriz Penissi
MVMariano E. Vera
Mariano E. Vera
MMMaría L. Mariani
María L. Mariani
MRMaría I. Rudolph
María I. Rudolph
JCJuan P. Ceñal
Juan P. Ceñal
RPRamón S. Piezzi
Ramón S. Piezzi

1 September 2014 in Phytomedicine
Verified
Journal Article
Closed access
FPFabio Andrés Persia
Fabio Andrés Persia
MMMaría Laura Mariani
María Laura Mariani
TFTeresa Hilda Fogal
Teresa Hilda Fogal
APAlicia Beatriz Penissi
Alicia Beatriz Penissi

1 August 2003
Verified
Journal Article
Closed access
APAlicia Beatriz Penissi
Alicia Beatriz Penissi
MRMaría I Rudolph
María I Rudolph
RPRamón S Piezzi
Ramón S Piezzi

1 October 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ASA.C. Arismendi Sosa
A.C. Arismendi Sosa
AIA.G. Salinas Ibáñez
A.G. Salinas Ibáñez
MCM.V. Pérez Chaca
M.V. Pérez Chaca
APAlicia Beatriz Penissi
Alicia Beatriz Penissi
NGNidia Gomez
Nidia Gomez
AVA.E. Vega
A.E. Vega

5 August 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
ASAndrea Celeste Arismendi Sosa
Andrea Celeste Arismendi Sosa
MMMaría Laura Mariani
María Laura Mariani
AVAlba Edith Vega
Alba Edith Vega
APAlicia Beatriz Penissi
Alicia Beatriz Penissi
Helicobacter pylori infection is widespread worldwide, with more than a half of the world population infected. H. pylori antibiotic-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. The search for new therapies based on plant extracts is a scientific interest field. The present study was conducted to evaluate the effect in vitro of extra virgin olive oil (EVOO), hydroxytyrosol (HT), and oleuropein (Olp) against two H. pylori strains and the effect in vivo of the oral administration of EVOO on the gastric mucosa of BALB/c mice infected with this microorganism. The broth microdilution method assayed the antibacterial in vitro activity of EVOO, HT, and Olp against H. pylori strains. For in vivo studies, male BALB/c mice were infected orally with an H. pylori suspension every 72 h. Four groups were used: (1) Control, (2) H. pylori-infected (HP), (3) EVOO, and (4) HP + EVOO. Mice were sacrificed at 7, 15, and 30 days. The stomachs were removed and observed under a microscope. Scoring of the degree of erosion was determined. Samples were processed by histological techniques for light microscopy. Macroscopic analysis showed that the presence of small erosions increased, both in number and size, in the infected group. Animals infected and treated with EVOO exhibited the presence of fewer erosions, which decreased in number as the treatment progressed. The mucosa of the control and EVOO groups showed normal histological characteristics at the three times studied. The mucosa of animals infected with H. pylori showed disruptions of the lining epithelium, damage to gastric glands, and vasodilation. The mucosa of animals infected with H. pylori and treated with EVOO showed morphological characteristics similar to those of normal and EVOO mucosa. For the first time, the current study showed the effect in vitro and in vivo of EVOO and combined administration of HT and Olp against H. pylori using an animal model. Future studies are needed to establish the mechanism of EVOO’s action at the gastric mucosa level to propose this product as a natural antimicrobial agent for the treatment of gastric H. pylori infections.